Currently out of the existing stock ratings of Joe Kim, 2 are a BUY (100%).
Analyst Joe Kim, currently employed at RBC, has had 50% of price targets met with an average potential upside of 38.84%, reached in 131 days on average.
Joe Kim has documented 4 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MIRM, Mirum Pharmaceuticals at 26-Feb-2026.
Analyst best performing recommendations are on MIRM (MIRUM PHARMACEUTICALS).
The best stock recommendation documented was for MIRM (MIRUM PHARMACEUTICALS) on 2/26/2026. The price target of $128 was fulfilled within 131 days with a profit of $35.81 (38.84%), with a performance score of 2.97.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Jun-2026
$194
$100.01 (106.40%)
$184
9 days ago
(11-Nov-2026)
0/4 (0%)
$99.58 (105.46%)
Buy Since 07-May-2026
$155
$61.01 (64.91%)
$155
16 days ago
(04-Nov-2026)
0/5 (0%)
$58.03 (59.84%)
Buy Since 19-May-2025
$202
$108.01 (114.92%)
$200
16 days ago
(04-Nov-2026)
4/12 (33.33%)
$105.03 (108.31%)
75
Buy Since 24-Oct-2023
$160
$66.01 (70.23%)
$140
16 days ago
(04-Nov-2026)
10/12 (83.33%)
$63.03 (65.00%)
243
Buy Since 20-Sep-2023
$167
$73.01 (77.68%)
$137
16 days ago
(04-Nov-2026)
15/26 (57.69%)
$70.03 (72.22%)
415
What Year was the first public recommendation made by Joe Kim?